Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.
暂无分享,去创建一个
M. Mihm | G. Dranoff | J. Ritz | R. Soiffer | H. Daley | C. Cutler | Haesook T. Kim | J. Antin | V. Ho | O. Pozdnyakova | E. Alyea | Natalie Bavli | C. Reynolds | J. Koreth | N. Souders | M. Piesche